100
Participants
Start Date
August 10, 2021
Primary Completion Date
August 10, 2025
Study Completion Date
August 10, 2025
Camrelizumab
2 cycles Camrelizumab before endoscopic surgery and one year after
Chemotherapy
2 cycles Gemcitabine based chemotherapy before endoscopic surgery, with or without after surgery
endoscopic surgery
standard endoscopic surgery for recurrent nasopharyngeal carcinoma
RECRUITING
Eye& ENT Hospital, Fudan University, Shanghai
NOT_YET_RECRUITING
Fujian Medical University Union Hospital, Fuzhou
NOT_YET_RECRUITING
Fujian Provincial Hospital, Fuzhou
NOT_YET_RECRUITING
Shenzhen Second People's Hospital, Shenzhen
NOT_YET_RECRUITING
The People's Hospital of Guangxi Zhuang Autonomous Region, Nanning
NOT_YET_RECRUITING
The First Affiliated Hospital of Nanchang University, Nanchang
NOT_YET_RECRUITING
Shanghai Zhongshan Hospital,Fudan University, Shanghai
Chinese Academy of Medical Sciences
OTHER
Eye & ENT Hospital of Fudan University
OTHER